16. ANTI-NEOPLASTIC AGENTS

ANTI-NEOPLASTIC AGENTS: A TEACHER’S COMPREHENSIVE GUIDE

Welcome, future pharmacists and healthcare professionals!

Cancer is one of the leading causes of death worldwide, and anti-neoplastic agents (anti-cancer drugs) are at the forefront of the fight against this devastating disease. These drugs are used for treating malignancies or cancerous growths—either alone (chemotherapy) or in combination with surgery or radiation therapy. As a pharmaceutical chemistry educator with years of experience teaching oncology pharmacology, I have observed that students often find this topic challenging due to the complex classifications and mechanisms. Let me tell you: Understanding anti-neoplastic agents is essential for every pharmacy professional.

In this comprehensive guide, I will walk you through the major classes of anti-neoplastic agents—alkylating agents, antimetabolites, natural products, antibiotics, enzymes, hormones, and miscellaneous agents. I will explain their classifications, mechanisms of action, uses, stability, and formulations. By the end of this article, you will have a thorough understanding of these essential pharmaceutical agents. Let us begin our journey!

Dpharmguru’s exam insights:

Anti-neoplastic agents are frequently tested in pharmacy exams. Remember the different classes: Alkylating agents (Cyclophosphamide, Busulfan), Antimetabolites (Mercaptopurine, Fluorouracil, Methotrexate), Natural products (Vinca alkaloids, Taxanes), and Antibiotics (Dactinomycin, Doxorubicin). Pay special attention to the mechanisms of action and classification—these are almost always asked in exams! Also, remember that cancer is classified into carcinoma, sarcoma, leukaemia, lymphoma, and CNS cancers.

INTRODUCTION TO CANCER

Cancer is a disease characterised by abnormal and uncontrolled cell division attacking the surrounding tissues and organs, and also the distant body parts by circulating with blood and lymph.

Classification of Cancer

• Carcinoma: Starts in the skin or tissues lining the internal organs. Sub-types include adenocarcinoma, basal cell carcinoma, squamous cell carcinoma, and transitional cell carcinoma.
• Sarcoma: Starts in the bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissues.
• Leukaemia: Starts in the blood-forming tissues (bone marrow) and produces numerous abnormal blood cells.
• Lymphoma and Myeloma: Starts in the cells of the immune system.
• Central Nervous System Cancers: Starts in the brain and spinal cord tissues.

CLASSIFICATION OF ANTI-NEOPLASTIC AGENTS

1. ALKYLATING AGENTS

1.1 Cyclophosphamide

Chemical Name: 2-[bis(2-chloroethyl)amino]-1,3,2λ⁵-oxazaphosphinan-2-one

Mechanism of Action: Cyclophosphamide is a cell cycle-non-specific cytotoxic agent. The hepatic cytochrome P-450 enzyme system activates cyclophosphamide to make it cytotoxic. It alkylates DNA and forms cross-links between DNA strands, interfering with DNA replication and transcription, ultimately resulting in cell death. Its activity is maximum when a cell is replicating its DNA.

Uses:

• Malignant lymphomas, multiple myeloma, leukaemia
• Mycosis fungoides, neuroblastoma
• Adenocarcinoma of the ovary, retinoblastoma
• Carcinoma of breast
• Biopsy-proven minimal change nephrotic syndrome in paediatrics

Stability & Storage: Refrigerate in glass containers for up to 14 days. Vials should be kept at or below 25°C (77°F).

Formulations: Injection, Powder for solution

Brand Names: Procytox, Cytoxan, Cycloxan, Endoxan

1.2 Busulfan

Chemical Name: 4-methylsulfonyloxybutyl methanesulfonate

Mechanism of Action: Busulfan is a bifunctional alkylating agent and cell cycle-non-specific. It interacts with the thiol groups of proteins and nucleic acids and forms DNA-protein and DNA-DNA cross-links, preventing the synthesis and function of DNA.

Uses:

• With cyclophosphamide as conditioning regimen before allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukaemia
• Pre-transplant conditioning regimen in bone marrow transplantation

Stability & Storage: Refrigerate intact vials between 2-8°C (36-46°F).

Formulations: Tablet, Solution

Brand Names: Busulfex, Myleran

Dpharmguru’s exam insights:

Alkylating agents are frequently tested. Remember: Cyclophosphamide requires hepatic activation and is cell cycle-non-specific. Busulfan is used for chronic myeloid leukaemia. A common exam question is: “Which alkylating agent is used as a conditioning regimen before bone marrow transplantation?” (Answer: Busulfan).

2. ANTIMETABOLITES

2.1 Mercaptopurine

Chemical Name: 3,7-dihydropurine-6-thione

Mechanism of Action: Mercaptopurine prevents purine metabolism, thus inhibits nucleic acid synthesis. It competes with hypoxanthine and guanine for hypoxanthine-guanine phosphoribosyltransferase (HGPRTase).

Uses: Remission induction and maintenance therapy of acute lymphatic leukaemia.

Stability & Storage: Keep at room temperature, free from heat and moisture. After opening, suspension can be kept for up to 6 weeks.

Formulations: Tablet, Suspension

Brand Names: Purixan, Purinethol

2.2 Fluorouracil (5-FU)

Chemical Name: 5-Fluoro-1H,3H-pyrimidine-2,4-dione

Mechanism of Action: Fluorouracil inhibits DNA synthesis by preventing the conversion of deoxyuridylic acid into thymidylic acid by thymidylate synthase. It forms a covalently bound ternary complex, preventing the formation of thymidylate from uracil, thus inhibiting DNA and RNA synthesis.

Uses:

• Acute lymphocytic leukaemia, Crohn’s disease, ulcerative colitis
• Colorectal, breast, ovarian, pancreatic, and gastric carcinomas
• With levamisole in colon cancer patients
• Topical application in superficial basal cell carcinomas

Stability & Storage: Stable in NS stored in polyolefin bags at 5°C ± 3°C for 28 days.

Formulations: Injections, Solutions

Brand Names: Actikerall, Carac, Efudex, Fluoroplex, Tolak

2.3 Methotrexate (MTX)

Chemical Name: (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid

Mechanism of Action: MTX binds to the active catalytic site of dihydrofolate reductase and disrupts the synthesis of tetrahydrofolate. This prevents the formation of DNA, RNA, and proteins. Inhibition can be reversed by administration of leucovorin (folinic acid rescue).

Uses:

• Acute lymphocytic leukaemia, choriocarcinoma
• Burkitt lymphoma in children, breast cancer
• Head and neck carcinomas
• Low doses against severe psoriasis and rheumatoid arthritis

Stability & Storage: Store between 15-25°C. After puncture, store between 2-8°C for maximum 30 days. Protect from light and freezing.

Formulations: Injectable solution, Powder for injection

Brand Names: Trexall, Xatmep

Dpharmguru’s exam insights:

Antimetabolites are frequently tested. Remember: Methotrexate inhibits dihydrofolate reductase and is rescued by leucovorin. 5-Fluorouracil inhibits thymidylate synthase. Mercaptopurine inhibits purine metabolism. A common exam question is: “What is the mechanism of action of methotrexate?” (Answer: Inhibits dihydrofolate reductase).

3. NATURAL PRODUCTS

3.1 Vinblastine Sulphate

Source: Natural alkaloid obtained from Catharanthus roseus (Madagascar periwinkle).

Mechanism of Action: Vinblastine exerts its antitumour activity by interacting with tubulin and inhibiting mitosis at metaphase. It binds to the microtubular proteins of the mitotic spindle, causing crystallisation of the microtubule and mitotic arrest or cell death.

Uses:

• Breast cancer, testicular cancer
• Lymphomas, neuroblastoma
• Hodgkin’s and non-Hodgkin’s lymphomas
• Mycosis fungoides, histiocytosis, Kaposi’s sarcoma

Stability & Storage: Refrigerate between 2-8°C. Keep in outer carton to protect from light.

Formulations: Injection solution, Powder

Brand Name: Velban H

3.2 Dactinomycin (Actinomycin D)

Source: High molecular weight antineoplastic antibiotic isolated from Streptomyces parvulus.

Mechanism of Action: Dactinomycin binds to DNA and blocks RNA transcription, impairing mRNA production and protein synthesis.

Uses:

• Wilms’ tumour
• Childhood rhabdomyosarcoma
• Ewing’s sarcoma
• Metastatic, non-seminomatous testicular cancer

Stability & Storage: Store between 20-25°C (68-77°F) away from light and humidity.

Formulation: Powder for injection

Brand Name: Cosmegen

3.3 Doxorubicin Hydrochloride

Source: Cytotoxic anthracycline antibiotic obtained from Streptomyces peucetius var. caesius.

Mechanism of Action: Doxorubicin exerts its antimitotic activity by forming complexes with DNA through intercalation between base pairs. It blocks the activity of topoisomerase II by stabilising the DNA-topoisomerase II complex.

Uses:

• Acute lymphoblastic and myeloblastic leukaemia
• Wilms’ tumour, neuroblastoma
• Soft tissue and bone sarcomas
• Breast, ovarian, bladder, thyroid, gastric carcinomas
• Hodgkin’s disease, malignant lymphoma
• Adjuvant therapy in breast cancer with axillary lymph node involvement

Stability & Storage: Store at 2-8°C.

Formulations: Powder for injection, Solution

Brand Names: Adriamycin, Adriamycin RDF, Rubex, Adriamycin PFS

Dpharmguru’s exam insights:

Natural products are frequently tested. Remember: Vinca alkaloids (Vinblastine, Vincristine) inhibit tubulin and are cell cycle-specific (M phase). Doxorubicin intercalates with DNA and inhibits topoisomerase II. Dactinomycin blocks RNA transcription. A common exam question is: “What is the source of vinca alkaloids?” (Answer: Catharanthus roseus).

4. MISCELLANEOUS AGENTS

4.1 Cisplatin

Chemical Name: (SP-4-2)-diamminedichloroplatinum (II)

Mechanism of Action: Cisplatin destroys cancerous cells by binding to DNA and interfering with its repair mechanism. It binds to the N7 position on guanine residues, forming DNA cross-links that distort the DNA shape and inhibit effective repair, ultimately causing cell death.

Uses:

• Metastatic testicular tumours
• Ovarian tumours
• Advanced bladder cancer

Stability & Storage: Physically and chemically stable in glass containers or diluted with 0.9% sodium chloride at room temperature (15-25°C) for at least 30 days.

Formulations: Injection, Solution

Brand Names: Platinol, Platinex, Cytoplatin-50, Neoplat-10, Cycokast-50

4.2 Dromostanolone Propionate

Dromostanolone is a synthetic androgen (male hormone) that acts by binding to androgen receptors.

Mechanism of Action: Dromostanolone attaches to the androgen receptor, resulting in downstream genetic transcriptional changes. Its antitumor effect appears related to reduction or competitive inhibition of prolactin or oestrogen receptors.

Uses: Prescribed for the treatment of breast cancer in women (withdrawn from the market).

Stability & Storage: Store at 0-4°C for short-term or -20°C for long-term in dry and dark places.

Formulations: Injection, Solutions

Brand Names: Drolban, Masteril, Masteron

Dpharmguru’s exam insights:

Miscellaneous agents are frequently tested. Remember: Cisplatin is a platinum-based drug that binds to DNA and forms cross-links. It is used for testicular, ovarian, and bladder cancers. A common exam question is: “What is the mechanism of action of cisplatin?” (Answer: Binds to DNA and interferes with repair).

COMPARISON: ANTI-NEOPLASTIC AGENT CLASSES

FREQUENTLY ASKED QUESTIONS (FAQs)

1. What is the difference between carcinoma and sarcoma?

Carcinoma starts in the skin or tissues lining internal organs (epithelial tissue). Sarcoma starts in the bone, cartilage, fat, muscle, or other connective tissues (mesenchymal tissue).

2. What is the mechanism of action of cyclophosphamide?

Cyclophosphamide is activated by hepatic cytochrome P-450 enzymes. It alkylates DNA and forms cross-links between DNA strands, interfering with DNA replication and transcription, ultimately causing cell death.

3. What is leucovorin rescue?

Leucovorin (folinic acid) is administered to rescue normal cells from the toxic effects of methotrexate. It bypasses the blocked dihydrofolate reductase enzyme and replenishes the folate pool, allowing normal cellular function.

4. What is the mechanism of action of vinca alkaloids?

Vinca alkaloids (Vinblastine, Vincristine) bind to tubulin and inhibit the formation of microtubules, causing mitotic arrest at metaphase and cell death.

5. What is the mechanism of action of cisplatin?

Cisplatin binds to DNA at the N7 position on guanine residues, forming cross-links that distort the DNA shape and inhibit effective repair, ultimately causing cell death.

6. What is the difference between leukaemia and lymphoma?

Leukaemia starts in the blood-forming tissues (bone marrow) and produces abnormal blood cells. Lymphoma starts in the cells of the immune system (lymphocytes).

SUMMARY

Anti-neoplastic agents are among the most powerful and complex medications in clinical practice. This guide covered the major classes:

• Alkylating Agents (Cyclophosphamide, Busulfan) alkylate DNA and form cross-links
• Antimetabolites (Mercaptopurine, Fluorouracil, Methotrexate) inhibit nucleic acid synthesis
• Natural Products (Vinblastine, Dactinomycin, Doxorubicin) from natural sources with various mechanisms
• Miscellaneous Agents (Cisplatin) bind to DNA and interfere with repair

As I always tell my students: “Understanding anti-neoplastic agents is essential for safe and effective cancer care. These drugs have the power to save lives—but they must be used with knowledge of their mechanisms, side effects, and dosing schedules.”

REFERENCES AND FURTHER READING

• Pharmacy Council of India (PCI). (2022). Pharmacology Syllabus. New Delhi: PCI.
• Rang, H. P., & Dale, M. M. (2021). Rang & Dale’s Pharmacology (9th ed.). Elsevier.
• Goodman, L. S., & Gilman, A. (2018). Goodman & Gilman’s The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill.
• Katzung, B. G. (2021). Basic and Clinical Pharmacology (15th ed.). McGraw-Hill.
• Williams, D. A., & Lemke, T. L. (2019). Foye’s Principles of Medicinal Chemistry (8th ed.). Wolters Kluwer.
• National Cancer Institute (NCI). (2022). Cancer Types and Treatment. Retrieved from https://www.cancer.gov.

Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals for medical concerns. Pharmaceutical regulations and guidelines may vary by region—always refer to your local regulatory authorities for specific requirements.

written by:
Dr. N. Sujith Kumar

Dr. N. Sujith Kumar is a pharmacy educator, Pharm.D graduate, and academic content creator from Jawaharlal Nehru Technological University Kakinada (JNTUK), where he completed his Doctor of Pharmacy (Pharm.D) degree between 2015 and 2021. He has more than 7 years of experience creating pharmacy educational content, writing study materials, and reviewing academic articles for pharmacy students. He has also contributed guest articles to pharmacy education platforms, including PharmD Guru. At D.PharmGuru, his work focuses on simplifying complex Diploma in Pharmacy (D.Pharmacy) subjects into easy-to-understand notes, practical explanations, and exam-oriented educational resources for students across India. His areas of focus include Human Anatomy and Physiology, Pharmaceutics, Pharmacology, Pharmaceutical Chemistry, Hospital and Clinical Pharmacy, and other core D.Pharmacy subjects.

For More Study Materials, Visit: www.dpharmguru.com